Research Area: Medicine
Authors zahira HAZIL
* salma HASSINA
ihssan HASNAOUI
louai SERGHINI
elhassan ABDALLAH
Department of Ophthalmology B, Rabat Specialty Hospital, CHU ibn Sina, Mohammed V Souissi University Rabat RABAT MOROCCOAbstractFuchs’ heterochromic iridocyclitis or Fuchs’ syndrome is a fairly common etiology of uveitis, but its pathophysiological mechanism remains poorly understood. The positive diagnosis remains clinical. Ocular hypertonia can complicate the disease, necessitating medical management and sometimes recourse to trabeculectomy. We report the case of a young patient with Fuchs heterochromia complicated by ocular hypertonia.
KeywordsHeterochromic iridocyclitis –hypertonia- catract
Doi : https://doi.org/10.5281/zenodo.10512692 PDF FileCiteHAZIL, Z., HASSINA, S., HASNAOUI, I., SERGHINI, L., & ABDELLAH, E. H. (2023). FUCHS' HETEROCHROMIC IRIDOCYCLITIS COMPLICATED BY HYPERTONIA: A CASE REPORT. International Journal of Science, Applications and Prosperity, 1(1), 13‑18.Licence
Copyright @ by the authors. This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
References[1] Becker MD, Zierhut M. Das Fuchs sche Uveitis Syndrome - Die Heterochromic ist keine Conditio sine qua none. Der Ophthalmologe 2005,102:733-744
[2] Quentin CD, Reiber H. Fuchs heterochromic cyclitis: rubella virus antibodies and genome in aqueous humor. Am J Ophthalmol. 2004;138(1):46-54
[3] Gordon L. Fuch’s heterochromic cyclitis: new clues regarding pathogenesis. Am J Ophthalmol. 2004;138(1):133-134
[4] Birnbaum AD, Tessler HH, Schultz KL, et al. Epidemiologic relationship between Fuchs heterochromic iridocyclitis and the United States rubella vaccination program. Am J Ophthalmol. 2007;144(3):424-428
[5] Teyssot N, Cassoux N, Lehoang P, et al. Fuchs heterochromic cyclitis and ocular toxocariasis. Am J Ophthalmol. 2005;139(5):915-6
[6] Toledo de Abreu M, Belfort R Jr, Hirata PS. Fuchs’ heterochromic cyclitis and ocular toxoplasmosis. Am J Ophthalmol. 1982;93(6):739-44
[7] Liesegang TJ. Clinical features and prognosis in Fuchs’ uveitis syndrome. Arch Ophthalmol 1982;100: 1622–1626
[8] Norrsell K, Sjodell L. Fuchs’ heterochromic uveitis: a longitudinal clinical study. Acta Ophthalmol. 2008;86(1):58-64
[9] Fuchs E. Uber komplikationen der Heterochromie. Z Augenheikd 1906,15:191-212
[10] Jones NP . Glaucoma in Fuchs’ heterochromic uveitis: aetiology management and outcome. Eye 1991,5:662-667
[11] La Hey E, Baarsma GS, De Vries J & Kijlstra A. Clinical analysis of Fuchs’heterochromic cyclitis. Doc Ophthalmol 1991; 78:225–235
[12] Whertheim MS, Mathers WD et al. In vivo confocal microscopy of keratic precipitates. Arch Ophthalmol 2004,122:1773-1781
[13] Franschetti À. Heterochromic cyclitis. Am J Ophthalmol 1955,54:50- 58
[14] Rothova A, La Hey E et al. Iris nodules in Fuchs’ heterochromic uveitis. Am J Ophthalmol. 1994; 118:338–342
[15] Rothova A. The riddle of fuchs heterochromic uveitis. Am J Ophthalmol. 2007;144(3):447-448
[16] Daus W, Schmidbauer J, Buschendorff P et al. Results of extracapsular cataract extraction with intra ocular lens implantation in eyes with uveitis and Fuchs’ heterochromic Iridocyclitis. German J Ophthalmol 1992,1:399-402
[17] Scott RA, Sullivan P, Aylward W, Pavesio C & Charteris D. The effect of pars plana vitrectomy in the management of Fuchs’ heterochromic cyclitis. Retina 2001, 21:312–316
[18] Amsler M, Verrey F.Hétérochromie de Fuchs et fragilité vasculaire. Ophtalmologica 1946, 111 :177-181
[19] Liesegang TJ. Clinical features and prognosis in Fuchs’ uveitis syndrome. Arch Ophthalmol 1982, 100:1622—6